Lymphoma

News from the 2009 annual meeting of the American Society of Clinical Oncology.

Researchers identify what survivors need to get physically active.

Childhood cancer survivors find lifelong care at ACE program.

CURE chooses the winning essay for it 2009 Extraordinary Healer Award for Oncology Nursing.

Reorienting kids to their academic and social lives after cancer.

Researchers of a follicular lymphoma trial hope that BiovaxID, a personalized vaccine, could help delay recurrences.

FDA approves Mozobil for non-Hodgkin lymphoma and myeloma, and Degarelix for advanced prostate cancer.

The risk of secondary cancers in childhood cancer survivors and what survivors can do to protect themselves.

Types of non-Hodgkin lymphoma.

The Leukemia and Lymphoma Society's "First Connection" program connects volunteers with newly diagnosed patients and caregivers to help them manage the many aspects of a cancer diagnosis.

Half of adult patients diagnosed with non-Hodgkin lymphoma are over age 60--oncologists must take into account age and associated complications.

Childhood cancer survivors skip needed mammograms

Childhood cancer patients make their mark in art exhibit

Clinical trials and other relevant topics were highlighted at the 2009 Texas Forum on Blood Cancers.

Why treatment of one cancer could lead to the diagnosis of a new cancer.

The gold standard in treating non-Hodgkin lymphoma gets new backup.

What I didn't know then about childhood cancer.

Treanda and Sancuso patch approved.

Flipping cancer's "off" switch.

Photographers offer services to childhood cancer patients.

News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.

New law funds pediatric cancer research.

Velcade is now available for newly diagnosed multiple myeloma patients and new drugs emerge as potential treatment to a serious side effect.

Childhood cancer garners sympathy from all, but drug development from few.

Adult cancers are biologically different from childhood cancer, resulting in different treatments and different success rates.